4//SEC Filing
David Nathaniel E 4
Accession 0000899243-21-026241
CIK 0001463361other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:22 PM ET
Size
5.7 KB
Accession
0000899243-21-026241
Insider Transaction Report
Form 4
David Nathaniel E
DirectorPresident
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24+11,918→ 11,918 totalExercise: $4.18Exp: 2031-06-23→ Common Stock (11,918 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2021 or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001559531
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:22 PM ET
- Size
- 5.7 KB